| TQVAX | VIVAX | TQVAX / VIVAX | |
| Total Expense Ratio | 0.99 | 0.17 | 582% |
| Annual Report Gross Expense Ratio | 2.31 | 0.17 | 1,359% |
| Fund Existence | 10 years | 34 years | - |
| Gain YTD | 14.572 | 14.451 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 83.5M | 245B | 0% |
| Annual Yield % from dividends | 1.12 | 1.76 | 64% |
| Returns for 1 year | 24.56 | 25.32 | 97% |
| Returns for 3 years | 44.39 | 57.90 | 77% |
| Returns for 5 years | 43.58 | 60.10 | 73% |
| Returns for 10 years | 128.21 | 166.33 | 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JAENX | 149.23 | 1.05 | +0.71% |
| Janus Henderson Enterprise T | |||
| SEKIX | 31.24 | N/A | N/A |
| DWS Emerging Markets Equity Inst | |||
| PDEAX | 26.10 | N/A | N/A |
| PGIM Jennison Emerging Markets Eq Opps A | |||
| HWLIX | 47.26 | N/A | N/A |
| Hotchkis & Wiley Large Cap Fdml Value I | |||
| RSECX | 17.64 | N/A | N/A |
| Russell Inv US Strategic Equity C | |||